Sometimes the unintended consequences of a treatment can seem worse than the disease. That's certainly the case for patients ...

A chef who was diagnosed with an aggressive form of breast cancer, which means he will have chemotherapy "for the rest of his life", is urging all men to "check their chests". Mat Kelly, 42, who lives ...

Phase 3 ARENSENS clinical trial results were presented at JADPRO 2025, indicating darolutamide plus ADT improved rPFS in prostate cancer.

A chef who was diagnosed with an aggressive form of breast cancer, which means he will have chemotherapy "for the rest of his ...

NICE recommendation of darolutamide plus hormone therapy for metastatic prostate cancer offers around 6000 patients in ...

Jennifer Munson’s decade-long study in Roanoke reveals that chemo drugs damage the brain’s waste-clearing vessels — a breakthrough that could lead to treatments for “chemo brain” and other ...

A powerful new drug combination—niraparib added to standard prostate cancer therapy—has been shown to significantly delay ...

A new study suggests that memory problems and difficulty concentrating after chemotherapy may stem from impaired lymphatic-system drainage caused by cancer drugs. Cancer is already a difficult ...

Imfinzi plus FLOT chemotherapy significantly improves overall survival in resectable G/GEJ adenocarcinoma compared to placebo ...

If approved alongside current SoC maintenance therapies, Tukysa could become the first update to the regimen for ...